Search

Your search keyword '"Silberberg DH"' showing total 135 results

Search Constraints

Start Over You searched for: Author "Silberberg DH" Remove constraint Author: "Silberberg DH"
135 results on '"Silberberg DH"'

Search Results

1. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

2. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016

3. Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [corrected] [published erratum appears in NEUROLOGY 2002 Aug 13;59(3):480].

7. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017

8. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016

9. Global, regional, and national levels and causes of maternal mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

10. Neurodevelopmental disorders in children aged 2-9 years: Population-based burden estimates across five regions in India.

11. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

12. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition.

14. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

16. Author response.

18. A double-blind, placebo-controlled trial of extracorporeal photopheresis in chronic progressive multiple sclerosis.

19. Specific treatment of multiple sclerosis.

20. Corticosteroids and optic neuritis.

22. Revised estimate of the prevalence of multiple sclerosis in the United States.

23. Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.

24. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

25. Expression of neural cell adhesion molecule in dysmyelinating mutants.

26. Cerebroside antibody titers in antisera capable of myelination inhibition and demyelination.

27. Occlusive migraine.

28. Generation and biological properties of a monoclonal antibody to galactocerebroside.

29. Fibroblast growth factor is a mitogen for oligodendrocytes in vitro.

30. Absence of expression of OKT8 antigen on cultured human, calf and rat oligodendrocytes.

31. Antibodies to galactocerebroside bind to oligodendroglia in suspension culture.

32. Remyelination follows antibody-induced central nervous system demyelination.

33. Rat oligodendrocytes have cell adhesion molecules.

34. Cranial arteritis.

35. Selected immunologic parameters of demyelinative diseases.

37. Tumor necrosis factor induces expression of MHC class I antigens on mouse astrocytes.

38. The mitotic history and radiosensitivity of developing oligodendrocytes in vitro.

39. Adult human brain expresses four different molecular forms of neural cell adhesion molecules.

40. Serological techniques for detection of antibody to galactocerebroside.

42. The isolation and long-term culture of oligodendrocytes from newborn mouse brain.

43. Coronavirus infection induces H-2 antigen expression on oligodendrocytes and astrocytes.

44. UDP-galactose: ceramide galactosyltransferase and 2',3'-cyclic nucleotide 3'-phosphohydrolase activities in cultured newborn rat cerebellum. Association with myelination and concurrent susceptibility to 5-bromodeoxyuridine.

45. Cultured human and rat oligodendrocytes and rat Schwann cells do not have immune response gene associated antigen (Ia) on their surface.

46. Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls.

47. Antiserum induced myelination inhibition in vitro without complement.

48. Scanning electron microscopy of organotypic rat cerebellum cultures.

49. Antibodies to oligodendroglia in patients with multiple sclerosis.

50. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.

Catalog

Books, media, physical & digital resources